David W Gryska insider trades
Open-market stock purchases and sales by David W Gryska, Unknown at Forte Biosciences, Inc, from SEC Form 4 filings since Jan 12, 2010.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +130%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 27, 2026 | FBRX Forte Biosciences, Inc | Sold (not open market) | — |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc | Sold (not open market) | $20K |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc | Sold (not open market) | $17.2K |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc | Sold (not open market) | — |
| Aug 27, 2026 | FBRX Forte Biosciences, Inc | Sold (not open market) | $234K |
| Jun 11, 2026 | DFTX Definium Therapeutics, Inc | Bought (not open market) | — |
| Jun 11, 2026 | DFTX Definium Therapeutics, Inc | Bought (not open market) | — |
| May 29, 2026 | FBRX Forte Biosciences, Inc | Bought (not open market) | — |
Companies traded
- FBRX Forte Biosciences, Inc: other filings, last Aug 27, 2026
- DFTX Definium Therapeutics, Inc: other filings, last Jun 11, 2026
- MNMD Mind Medicine (MindMed) Inc: 2 buys, last Jun 12, 2025
- SGEN Seagen Inc: 24 sales, last Dec 14, 2023
- AERI Aerie Pharmaceuticals Inc: other filings, last Nov 21, 2022
- GWPH GW Pharmaceuticals plc: other filings, last May 5, 2021
- PDLI PDL Biopharma, Inc: 6 sales, last Dec 30, 2020
- INCY Incyte Corp: 8 sales, last Jul 16, 2018
- HPTX Hyperion Therapeutics Inc: other filings, last Apr 15, 2013
- CELG Celgene Corp /de/: 4 sales, last Jul 13, 2010